{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:42:22Z","timestamp":1740109342918,"version":"3.37.3"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>A quality indicator (QI) for the treatment of systemic lupus erythematosus (SLE) during pregnancy and childbirth that is useful for sharing standard treatment policies has not yet been developed. This study aimed to develop a QI for SLE associated with pregnancy and childbirth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>To identify candidate QIs, we conducted a systematic literature review on the development of QIs for SLE related to pregnancy and childbirth and on clinical practice guidelines. Candidate QI items were extracted from the final selected articles, and a first evaluation, panel meeting, and second evaluation were conducted to determine whether the candidate items were appropriate as QIs. Items for which all panel members reached a consensus were designated pregnancy and childbirth-related SLE QIs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Four articles on SLE QI development and 28 practice guidelines were listed through abstract\/text screening. Based on these studies, 52 candidate QIs were extracted that were limited to items related to pregnancy and childbirth and 41 items were selected on which all panel members agreed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We developed pregnancy-related SLE QIs using the RAND\/UCLA method and selected 41 items, which could be used clinically.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mr\/roae029","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T04:45:44Z","timestamp":1712637944000},"page":"1170-1177","source":"Crossref","is-referenced-by-count":0,"title":["Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4920-3425","authenticated-orcid":false,"given":"Mika","family":"Hatano","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-3962","authenticated-orcid":false,"given":"Nobuyuki","family":"Yajima","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University School of Medicine , Tokyo,","place":["Japan"]},{"name":"Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health , Kyoto,","place":["Japan"]},{"name":"Department of Clinical Epidemiology, Fukushima Medical University , Fukushima City,","place":["Japan"]},{"name":"Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University , Fukushima,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yanai","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Ishii","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University School of Medicine , Tokyo,","place":["Japan"]},{"name":"Oku Medical Clinic , Osaka,","place":["Japan"]},{"name":"Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine\/School of Public Health, Kyoto University , Kyoto,","place":["Japan"]},{"name":"Scientific Research WorkS Peer Support Group (SRWS-PSG) , Osaka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhisa","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Prefecture General Medical Center , Nara,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University , Sapporo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Kameda","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Toho University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Nippon Medical School , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health , Fukuoka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Laboratory Medicine, Kanazawa University , Kanazawa,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Mie University Hospital , Mie,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Faculty of Medicine, Osaka Medical and Pharmaceutical University , Osaka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University , Osaka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Miyamae","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women\u2019s Medical University , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Murashima","sequence":"additional","affiliation":[{"name":"Japan Drug Information Institute in Pregnancy National Center for Child Health and Development , Tokyo,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"author":"Japan College of Rheumatology","key":"2024110410412346000_R1","article-title":"Guidelines for Systemic Lupus Erythematosus (SLE)"},{"author":"Research Group for \u201cDevelopment of Treatment Guidelines for Pregnancy and Childbirth in Female Patients with Rheumatoid Arthritis (RA) and Inflammatory Bowel Disease (IBD)\u201d","key":"2024110410412346000_R2","article-title":"Treatment Guidelines for Pregnancy and Childbirth in Female Patients with Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) and Inflammatory Bowel Disease (IBD) [Internet]"},{"key":"2024110410412346000_R3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.326.7393.816","article-title":"Research methods used in developing and applying quality indicators in primary care","volume":"326","author":"Campbell","year":"2003","journal-title":"BMJ"},{"key":"2024110410412346000_R4","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0277-9536(00)00057-5","article-title":"Defining quality of care","volume":"51","author":"Campbell","year":"2000","journal-title":"Soc Sci Med"},{"key":"2024110410412346000_R5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.24356","article-title":"A quality indicator set for systemic lupus erythematosus","volume":"61","author":"Yazdany","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2024110410412346000_R6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.autrev.2010.12.008","article-title":"Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice","volume":"10","author":"Mosca","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2024110410412346000_R7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/acr.20327","article-title":"Systematic review of the literature informing the systemic lupus erythematosus indicators project: reproductive health care quality indicators","volume":"63","author":"Gillis","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2024110410412346000_R8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/annrheumdis-2021-220438","article-title":"Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients","volume":"80","author":"Chavatza","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/14397595.2019.1621419","article-title":"The development of quality indicators for systemic lupus erythematosus using electronic health data: a modified RAND appropriateness method","volume":"30","author":"Yajima","year":"2020","journal-title":"Mod Rheumatol"},{"key":"2024110410412346000_R10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmjqs-2013-002494","article-title":"Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study","volume":"23","author":"Yazdany","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"2024110410412346000_R11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038295","article-title":"Can the adherence to quality of care indicators for early rheumatoid arthritis in clinical practice reduce risk of hospitalisation? Retrospective cohort study based on the Record Linkage of Rheumatic Disease study of the Italian Society for Rheumatology","volume":"10","author":"Zanetti","year":"2020","journal-title":"BMJ Open"},{"key":"2024110410412346000_R12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2307\/3348969","article-title":"Evaluating the quality of medical care","volume":"44","author":"Donabedian","year":"1966","journal-title":"Milbank Mem Fund Q"},{"volume-title":"Clinical Practice Guidelines We Can Trust","year":"2011","author":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","key":"2024110410412346000_R13"},{"key":"2024110410412346000_R14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.20248","article-title":"Measuring quality in arthritis care: methods for developing the Arthritis Foundation\u2019s quality indicator set","volume":"51","author":"MacLean","year":"2004","journal-title":"Arthritis Rheum"},{"article-title":"The RAND\/UCLA Appropriateness Method User\u2019s Manual","year":"2001","author":"Fitch","key":"2024110410412346000_R15"},{"key":"2024110410412346000_R16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006682","article-title":"Standardised method for reporting exercise programmes: protocol for a modified Delphi study","volume":"4","author":"Slade","year":"2014","journal-title":"BMJ Open"},{"key":"2024110410412346000_R17","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association\u2013European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R18","first-page":"1","article-title":"Diagnosis and treatment of lupus nephritis. Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish Society of Internal Medicine (SEMI) and Spanish Society of Nephrology (S.E.N.)","volume":"32","author":"Ruiz Irastorza","year":"2012","journal-title":"Nefrolog\u00eda"},{"key":"2024110410412346000_R19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ard.2009.117200","article-title":"European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies","volume":"69","author":"Mosca","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics","volume":"673","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R21","first-page":"107","article-title":"Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE)","volume":"25","author":"Mosca","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"2024110410412346000_R22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/rir-2020-0009","article-title":"2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus","volume":"1","author":"Li","year":"2020","journal-title":"Rheumatol Immunol Res"},{"key":"2024110410412346000_R23","doi-asserted-by":"crossref","DOI":"10.1186\/s42358-020-00125-9","article-title":"Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)","volume":"60","author":"Balbi","year":"2020","journal-title":"Adv Rheumatol"},{"key":"2024110410412346000_R24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpm-2020-0543","article-title":"Neonatal lupus erythematosus \u2013 practical guidelines","volume":"49","author":"Derdulska","year":"2021","journal-title":"J Perinat Med"},{"key":"2024110410412346000_R25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.reuma.2019.09.002","article-title":"Pregnancy control in patients with systemic lupus erythematosus and antiphospholipid syndrome. Part 1: Infertility, ovarian preservation and preconception assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER)","volume":"17","author":"Espinosa","year":"2021","journal-title":"Reumatol Clin"},{"key":"2024110410412346000_R26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kex291","article-title":"The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: executive summary","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2024110410412346000_R30","first-page":"A43","article-title":"CS-36 Recommendations for the assessment of systemic lupus erythematosus in Canada","volume":"5","author":"Keeling","year":"2018","journal-title":"Lupus Sci Med"},{"key":"2024110410412346000_R31","article-title":"GRADE-based recommendations for the diagnosis and monitoring of systemic lupus erythematosus in Canada","volume":"69","author":"Keeling","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024110410412346000_R32","article-title":"Recommendations for the diagnosis and monitoring of systemic lupus erythematosus in Canada","volume":"44","author":"Keeling","year":"2017","journal-title":"J Rheumatol"},{"key":"2024110410412346000_R33","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3899\/jrheum.171459","article-title":"Canadian Rheumatology Association recommendations for the assessment and monitoring of systemic lupus erythematosus","volume":"45","author":"Keeling","year":"2018","journal-title":"J Rheumatol"},{"key":"2024110410412346000_R34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.autrev.2017.04.011","article-title":"International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus","volume":"16","author":"Kleinmann","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2024110410412346000_R35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.reuma.2016.05.003","article-title":"Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding","volume":"13","author":"Mart\u00ednez L\u00f3pez","year":"2017","journal-title":"Reumatol Clin"},{"key":"2024110410412346000_R36","first-page":"883","article-title":"Consensus statement for the evaluation and management of patients with autoimmune and inflammatory diseases during fertility, pregnancy, post-partum and breastfeeding","volume":"75","author":"Martnez-Lpez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R37","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/annrheumdis-2018-213512","article-title":"First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)","volume":"77","author":"Pons-Estel","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2024110410412346000_R39","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024110410412346000_R40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reuma.2018.03.011","article-title":"Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology","volume":"15","author":"Xibill\u00e9-Friedmann","year":"2019","journal-title":"Reumatol Clin"},{"key":"2024110410412346000_R41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.reuma.2014.11.005","article-title":"Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology Part I","volume":"11","author":"Saavedra Salinas","year":"2015","journal-title":"Reumatol Clin"},{"key":"2024110410412346000_R42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.reuma.2014.12.004","article-title":"Clinical practice guidelines for the management of pregnancy in women with autoimmune rheumatic diseases of the Mexican College of Rheumatology. Part II","volume":"11","author":"Saavedra Salinas","year":"2015","journal-title":"Reumatol Clin"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roae029\/58937908\/roae029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/34\/6\/1170\/60412078\/roae029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/34\/6\/1170\/60412078\/roae029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T10:41:38Z","timestamp":1730716898000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/34\/6\/1170\/7642498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,4,8]]},"published-print":{"date-parts":[[2024,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roae029","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"type":"print","value":"1439-7595"},{"type":"electronic","value":"1439-7609"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,4,8]]}}}